| Richard Anthony Dentico, MD | |
|
1910 South Rd, Poughkeepsie, NY 12601-6027 | |
| (845) 454-0120 | |
| (845) 454-6080 |
| Full Name | Richard Anthony Dentico |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 20 Years |
| Location | 1910 South Rd, Poughkeepsie, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962643866 | NPI | - | NPPES |
| 03110969 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 252207 (New York) | Primary |
| 2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | 252207 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northern Dutchess Hospital | Rhinebeck, NY | Hospital |
| Ellenville Regional Hospital | Ellenville, NY | Hospital |
| Vassar Brothers Medical Center | Poughkeepsie, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopaedic And Neurosurgery Specialists, Pllc | 5294628947 | 208 |
News Archive
AstraZeneca and Abbott announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) for the New Drug Application (NDA) for CERTRIAD™ (rosuvastatin / fenofibric acid delayed release) Capsules.
Leading experts from the European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) have published a timely position paper on the association between subtrochanteric femoral (upper thigh bone) fractures and long-term treatment with bisphosphonates.
The U.S. Food and Drug Administration today approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts of the body or can't be removed by surgery, and that has a certain type of abnormal gene (BRAF V600E or V600K mutation).
New research published in Nutrients Journal has highlighted a strong link between low vitamin K status and cardiovascular mortality.
› Verified 4 days ago
| Entity Name | Orthopedic Assoc Of Dutchess County P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386661452 PECOS PAC ID: 5890608715 Enrollment ID: O20031107000062 |
News Archive
AstraZeneca and Abbott announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) for the New Drug Application (NDA) for CERTRIAD™ (rosuvastatin / fenofibric acid delayed release) Capsules.
Leading experts from the European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) have published a timely position paper on the association between subtrochanteric femoral (upper thigh bone) fractures and long-term treatment with bisphosphonates.
The U.S. Food and Drug Administration today approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts of the body or can't be removed by surgery, and that has a certain type of abnormal gene (BRAF V600E or V600K mutation).
New research published in Nutrients Journal has highlighted a strong link between low vitamin K status and cardiovascular mortality.
› Verified 4 days ago
| Entity Name | Orthopaedic & Neurosurgery Specialists, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033318720 PECOS PAC ID: 5294628947 Enrollment ID: O20170828001424 |
News Archive
AstraZeneca and Abbott announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) for the New Drug Application (NDA) for CERTRIAD™ (rosuvastatin / fenofibric acid delayed release) Capsules.
Leading experts from the European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) have published a timely position paper on the association between subtrochanteric femoral (upper thigh bone) fractures and long-term treatment with bisphosphonates.
The U.S. Food and Drug Administration today approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts of the body or can't be removed by surgery, and that has a certain type of abnormal gene (BRAF V600E or V600K mutation).
New research published in Nutrients Journal has highlighted a strong link between low vitamin K status and cardiovascular mortality.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard Anthony Dentico, MD 1910 South Rd, Poughkeepsie, NY 12601-6027 Ph: (845) 454-0120 | Richard Anthony Dentico, MD 1910 South Rd, Poughkeepsie, NY 12601-6027 Ph: (845) 454-0120 |
News Archive
AstraZeneca and Abbott announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) for the New Drug Application (NDA) for CERTRIAD™ (rosuvastatin / fenofibric acid delayed release) Capsules.
Leading experts from the European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) have published a timely position paper on the association between subtrochanteric femoral (upper thigh bone) fractures and long-term treatment with bisphosphonates.
The U.S. Food and Drug Administration today approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts of the body or can't be removed by surgery, and that has a certain type of abnormal gene (BRAF V600E or V600K mutation).
New research published in Nutrients Journal has highlighted a strong link between low vitamin K status and cardiovascular mortality.
› Verified 4 days ago
Amy Wierzchowski, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 45 Reade Pl, Poughkeepsie, NY 12601 Phone: 845-483-6217 Fax: 845-483-6108 | |
Daniel Emery Schafer, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1910 South Rd, Poughkeepsie, NY 12601 Phone: 454-548-3778 Fax: 845-271-2901 | |
Ravichandra Reddy, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1 Webster Ave, Atrium At St Francis #301, Poughkeepsie, NY 12601 Phone: 845-483-5865 Fax: 845-483-5787 | |
Mark P Bodack, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1 Webster Ave, Atrium At Sfh, Poughkeepsie, NY 12601 Phone: 845-483-5780 Fax: 845-483-5787 | |
Samant S. Virk, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1910 South Rd, Poughkeepsie, NY 12601 Phone: 845-454-0120 Fax: 845-454-6080 | |
Dr. Vishal P. Rekhala, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1910 South Rd, Poughkeepsie, NY 12601 Phone: 845-454-0120 Fax: 845-454-0120 | |
Dr. Lydia B Habacon, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 10 Ross Cir, Poughkeepsie, NY 12601 Phone: 845-452-8000 |